Preconditioning with oxidative stress has been demonstrated in vitro to stimulate the cellular adaptation to subsequent severe oxidative stress. However, it is uncertain whether this preconditioning works in vivo. In the present study, we examined in vivo the beneficial effect of oxidative preconditioning. After rats were pretreated with whole-body hyperoxygenation (100% 02 at 3 atmosphere for 20 mins, four cycles with 20-min intermission), isolated hearts were subjected to 45-min ischemia followed by 90-min reperfusion. This hyperoxic preconditioning significantly reduced infarct size, cytochrome-c release, DNA fragmentation, and terminal deoxynucleotidyl transferase-mediated dUTD nick-end labeling-positive cell frequency in the left ventricle, biphasically with an early (30-min) and a delayed (48-hr) effect after the hyperoxygenation. Mechanistically, the NF-κB activity and Bcl-2 expression were enhanced in the hearts, and a NF-κB inhibitor, pyrrolidine dithiocarbamate, abolished the Bcl-2 induction as well as the infarct-limiting effect. An antioxidant, N-acetylcysteine, and protein kinase C (PKC) inhibitors chelerythrine and Gö 6983 also blocked the preconditioning effects. These results indicate that hyperoxia induces myocardial tolerance against ischemia-reperfusion injury in association with Bcl-2 induction by NF-κB activation through reactive oxygen species and PKC-dependent signaling pathway.
FerrariR, CeconiC, CurelloS, CargnoniA, De GiuliF, VisioliO. Occurrence of oxidative stress during myocardial reperfusion. Mol Cell Biochem111: 61–69, 1992.
2.
RubinoA, YellonDM. Ischaemic preconditioning of the vasculature: an overlooked phenomenon for protecting the heart?Trends Pharmacol Sci21: 225–230, 2000.
ArnaudC, JoyeuxM, GarrelC, Godin-RibuotD, DemengeP, RibuotC. Free-radical production triggered by hyperthermia contributes to heat stress-induced cardioprotection in isolated rat hearts. Br J Pharmacol135: 1776–1782, 2002.
5.
SunJZ, TangXL, ParkSW, QiuY, TurrensJF, BolliR. Evidence for an essential role of reactive oxygen species in the genesis of late preconditioning against myocardial stunning in conscious pigs. J Clin Invest97: 562–576, 1996.
6.
Vanden HoekTL, BeckerLB, ShaoZ, LiC, SchumackerPT. Reactive oxygen species released from mitochondria during brief hypoxia induce preconditioning in cardiomyocytes. J Biol Chem273: 18092–18098, 1998.
7.
DasDK, EngelmanRM, MaulikN. Oxygen free radical signaling in ischemic preconditioning. Ann NY Acad Sci874: 49–65, 1999.
8.
TrinoI, D'andreaD, EramoN, ScognamiglioA, De SimoneC, ViolanteA, EspositoA, ChiarielloM, AmbrosioG. Oxygen radicals can induce preconditioning in rabbit hearts. Circ Res80: 743–748, 1997.
9.
TibblesPM, EdelsbergJS. Hyperbaric-oxygen therapy. N Engl J Med334: 1642–1648, 1996.
ClarkJM. Oxygen toxicity. In: BanettPB, ElliotDH, Eds. The Physiology and Medicine of Diving. London: Saunders, p 121, 1993.
12.
KimCH, ChoiH, ChunYS, KimGT, ParkJW, KimMS. Hyperbaric oxygenation pretreatment induces catalase and reduces infarct size in ischemic rat myocardium. Pfliigers Arch Eur J Physiol442: 519–525, 2001.
13.
KimCH, ChoYS, ChunYS, ParkJW, KimMS. Early expression of myocardial HIF-1 alpha in response to mechanical stresses: regulation by stretch-activated channels and the phosphatidylinositol 3-kinase signaling pathway. Circ Res90: E25–E33, 2002.
14.
StaleyK, BlaschkeAJ, ChunJ. Apoptotic DNA fragmentation is detected by semi-quantitive ligation mediated PCR of blunt DNA ends. Cell Death Differ4: 66–75, 1997.
15.
CurrieRW, TanguayR. Analysis of RNA for transcripts for catalase and HSP71 in rat hearts after in vivo hyperthermia. Biochem Cell Biol69: 375–382, 1991.
ThomtonJ, StriplinS, LiuGS, SwaffordA, StanleyAW, Van WinkleDM, DowneyJM. Inhibition of protein synthesis does not block myocardial protection afforded by preconditioning. Am J Physiol259: H1822–H1825, 1990.
18.
RowlandRT, MengX, ClevelandJC, MeldrumDR, HarkenAH, BrownJM. Cardioadaptation induced by cyclic ischemic preconditioning is mediated by translational regulation of de novo protein synthesis. J Surg Res71: 155–160, 1997.
19.
MaulikN, SatoM, PriceBD, DasDK. An essential role of NFkappaB in tyrosine kinase signaling of p38 MAP kinase regulation of myocardial adaptation to ischemia. FEBS Lett429: 365–369, 1998.
20.
MorganEN, BoyleEMJr., YunW, Griscavage-EnnisJM, FarrAL, CantyTGJr, PohlmanTH, VerrierED. An essential role for NFkappaB in the cardioadaptive response to ischemia. Ann Thorac Surg68: 377–382, 1999.
21.
XuanYT, TangXL, BanerjeeS, TakanoH, LiRC, HanH, QiuY, LiJJ, BolliR. Nuclear factor-kappaB plays an essential role in the late phase of ischemic preconditioning in conscious rabbits. Circ Res84: 1095–1109, 1999.
22.
TahepoldP, VaageJ, StarkopfJ, ValenG. Hyperoxia elicits myocardial protection through a nuclear factor kappaB-dependent mechanism in the rat heart. J Thorac Cardiovasc Surg125: 650–660, 2003.
23.
MaulikN, SasakiH, AddyaS, DasDK. Regulation of cardiomyocyte apoptosis by redox-sensitive transcription factors. FEBS Lett485: 7–12, 2000.
NakamuraM, WangNP, ZhaoZQ, WilcoxJN, ThouraniV, GuytonRA, Vinten-JohansenJ. Preconditioning decreases Bax expression, PMN accumulation and apoptosis in reperfused rat heart. Cardiovasc Res45: 661–670, 2000.
26.
DixonEP, StephensonDT, ClemensJA, LittleSP. Bcl-Xshort is elevated following severe global ischemia in rat brains. Brain Res776: 222–229, 1997.
27.
TamataniM, MitsudaN, MatsuzakiH, OkadoH, MiyakeS, VitekMP, YamaguchiA, TohyamaM. A pathway of neuronal apoptosis induced by hypoxia/reoxygenation: roles of nuclear factor-kappaB and Bcl-2. J Neurochem75: 683–693, 2000.
28.
DimmelerS, BreitschopfK, HaendelerJ, ZeiherAM. Dephosphorylation targets Bcl-2 for ubiquitin-dependent degradation: a link between the apoptosome and the proteasome pathway. J Exp Med189: 1815–1822, 1999.
29.
BreitschopfK, HaendelerJ, MalchowP, ZeiherAM, DimmelerS. Posttranslational modification of Bcl-2 facilitates its proteasome-dependent degradation: molecular characterization of the involved signaling pathway. Mol Cell Biol20: 1886–1896, 2000.
30.
BogdanovMB, FerranteRJ, MuellerG, RamosLE, MartinouJC, BealMF. Oxidative stress is attenuated in mice overexpressing Bcl-2. Neurosci Lett262: 33–36, 1999.
AkaoY, OtsukiY, KataokaS, ItoY, TsujimotoY. Multiple subcellular localization of bcl-2: detection in nuclear outer membrane, endoplasmic reticulum membrane, and mitochondrial membranes. Cancer Res54: 2468–2471, 1994.
33.
MurphyAN. Ca2-l-mediated mitochondrial dysfunction and the protective effects of Bcl-2. Ann NY Acad Sci893: 19–32, 1999.
34.
KroemerG, DallaportaB, Resche-RigonM. The mitochondrial death/life regulator in apoptosis and necrosis. Annu Rev Physiol60: 619–642, 1998.
35.
LemastersJJ, NieminenAL, QianT, TrostLC, ElmoreSP, NishimuraY, CroweRA, CascioWE, BradhamCA, BrennerDA, HermanB. The mitochondrial permeability transition in cell death: a common mechanism in necrosis, apoptosis and autophagy. Biochim Biophys Acta1366: 177–196, 1998.
36.
HalestrapAP, KerrPM, JavadovS, WoodfieldKY. Elucidating the molecular mechanism of the permeability transition pore and its role in reperfusion injury of the heart. Biochim Biophys Acta1366: 79–94, 1998.
37.
BrocheriouV, HagegeAA, OubenaissaA, LambertM, MalletVO, DuriezM, WassefM, KahnA, MenascheP, GilgenkrantzH. Cardiac functional improvement by a human Bcl-2 transgene in a mouse model of ischemia/reperfusion injury. J Gene Med2: 326–333, 2000.
38.
ChenZ, ChuaCC, HoYS, HamdyRC, ChuaBH. Overexpression of Bcl-2 attenuates apoptosis and protects against myocardial I/R injury in transgenic mice. Am J Physiol280: H2313–H2320, 2001.
39.
YamabeK, ShimizuS, KamiikeW, WaguriS, EguchiY, HasegawaJ, OkunoS, YoshiokaY, ItoT, SawaY, UchiyamaY, TsujimotoY, MatsudaH. Prevention of hypoxic liver cell necrosis by in vivo human bcl-2 gene transfection. Biochem Biophys Res Commun243: 217–223, 1998.
40.
BilbaoG, ContrerasJL, EckhoffDE, MikheevaG, KrasnykhV, DouglasJT, ThomasFT, ThomasJM, CurielDT. Reduction of ischemia-reperfusion injury of the liver by in vivo adenovirus-mediated gene transfer of the anti-apoptotic Bcl-2 gene. Ann Surg230: 185–193, 1999.
